Key result
Norovirus gastroenteritis disproportionately burdens adults over 65 with severe disease, higher hospitalization, and increased mortality.
Why the study?
Adults older than 65 years bear a significant proportion of the norovirus burden, with a disease course that is often more severe and protracted.
This narrative review summarizes the epidemiology, clinical manifestations, prevention, and management of norovirus disease, highlighting its significant burden and severity in adults older than 65 years.
This is the authors' abstract. We don't add key points for this paper.
Norovirus, a leading cause of gastroenteritis outbreaks worldwide, results in substantial direct and indirect healthcare costs. Adults older than 65 years of age bear a significant proportion of the disease burden, and the disease course in this population is often more severe and protracted. In this narrative review, we discuss the epidemiology of norovirus infection, mechanisms of pathogenesis, and transmission pertinent to outbreaks along with infection prevention and control efforts. We also describe the clinical manifestations of norovirus disease with a focus on individuals older than 65 years of age, diagnosis and available treatment options, and the challenges and progress within vaccine development.
Answers are grounded in this paper and cite their sources.
May prompt heightened vigilance in adults >65; leaves open need for interventional trials on prevention.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2022) conducted a review in Norovirus infection. Norovirus gastroenteritis disproportionately affects adults older than 65 years, who experience more severe and protracted disease courses, higher hospitalization rates, and increased mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: